Diabetes Clinical Trial - Dr. Dipnarine Maharaj

Diabetes Clinical Trial - Dr. Dipnarine Maharaj

 

 

The Stem Cell Cancer Regenerative Medicine Research Foundation Inc. is seeking funding for research to uncover the inflammatory basis of degenerative diseases such as Diabetes Mellitus and to determine whether treating the inflammation will play a crucial role in altering the underlying biology of this disease which affects 24 million people in the United States and 241 million people worldwide. 

Diabetes Expert Dr. Dipnarine Maharaj M.D. FACP

 

Inflammation is part of the body’s normal healing response to injury. When blood vessels of  organs such as the pancreas suffer injury as a result of the effects of obesity, excessive sugar intake, smoking and abnormal cholesterol, for instance, the immune system as part of the inflammatory response dispatches cells to repair the damage. But in the face of a constant assault by such irritants over decades, possibly abetted by genetics that system can go into overdrive. Instead of protecting the vessels the inflammation becomes chronic and this leads to the body’s  decreased ability to  metabolize blood sugar and abnormal  insulin production by the pancreas which results in Diabetes. The inflammation of the blood vessels also  lead to the accumulation and potential rupture of arterial deposits called plaque that can cause heart attack and strokes which are common complications of Diabetes.

The goals of the Stem Cell Cancer Regenerative Medicine Research Foundation Inc. Is dedicated to taking actions that will: predict those patients at risk for development of the disease before the actual clinical onset, to prevent the disease; and study the use of stem cells for tissue repair.

The Stem Cell Cancer Regenerative Medicine Research Foundation’s support of the research being conducted by the South Florida Bone Marrow Stem Cell Transplant Institute under the direction of Medical Director, Dipnarine Maharaj, MD, FACP.